Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.00%
)
US TECH 100
28,590.00
(
0.01%
)
Dow Jones
49,693.20
(
0.00%
)
Brent Oil
102.62
(
-1.04%
)
Bitcoin
79,346.00
(
0.08%
)
News Focus
News Focus
Post# of 257557
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 154459

Friday, 01/11/2013 2:55:30 PM

Friday, January 11, 2013 2:55:30 PM

Post# of 257557

Ouch. MRK has dropped plans to seek approval for Tredaptive in the US; in countries where the drug is already approved, sales will presumably plummet.

"MRK is taking steps to suspend the availability of TREDAPTIVE™ (extended-release niacin/laropiprant) tablets worldwide."

http://www.mercknewsroom.com/press-release/research-and-development-news/merck-provides-update-next-steps-tredaptive-extended-rel
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today